Circulating tumor necrosis factor α is elevated in male but not in female patients with type II diabetes mellitus

Hormone and Metabolic Research

Volumn 29, Issue 3, 1997, Pages 111-114

  Pfeiffer, A ^a   Janott, J ^a   Mohlig M ^a   Ristow, M ^a   Rochlitz, H ^a   Busch, K ^a   Schatz, H ^a   Schifferdecker, E ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

cytokine, effect on triglycerides; diabetes, CHD; diabetes, retinopathy; NIDDM; TNF

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANGIOGRAPHY; ARTICLE; BLOOD ANALYSIS; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0030978036     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979001     Document Type: Article

References (19)

1. Feingold KR, Grunfeld C: Role of cytokines in inducing hyperlipidemia. Diabetes 41 (Suppl 2): 97-101 (1992).
2. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor a inhibits signalling from the insulin receptor. Proc Natl Acad Sci USAS 91: 4854-4858 (1994).
3. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259: 87-91 (1993).
4. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278 (1994).
5. Hou J, Baichwal V, Cao Z: Regulatory elements and transcription factors controlling basal and cytokine-induce expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 91: 11641-11645 (1994).
6. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69 (1996).
7. Jarrett RJ: Risk factors for coronary heart disease in diabetes mellitus. Diabetes 41 (Suppl 2): 1-3 (1992).
8. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52 (1992).
9. Mandrup-Poulsen T, Pociot F, Molvig J, Shapiro L, Nilsson P, Emdal T, Roder M, Kjems LL, Dinarello CA, Nerup J: Monokine antagonism is reduced in patients with IDDM. Diabetes 43: 1242-1247 (1994).
10. Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-2, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77 (4): 1072-1077 (1993).
11. Pacifi R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV: Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88: 5134-5138 (1991).
12. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729 (1984).
13. Rothe H, Ongoren C, Martin S, Rosen P, Kolb H: Abnormal TNF-α production in diabetes-prone BB rats: enhanced TNF-α expression and defective PGE2 feedback inhibition. Immunology 81: 407-413 (1994).
14. Starnes Jr HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF: Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 82: 1321-1325 (1988).
15. Tanaka S, Seino H, Satoh J, Fujii N, Rikiishi H, Zhu XP, Takahashi K, Sagara M, Nobunaga T, Toyota T: Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats. Clin Immunol Immunopathol 62: 258-263 (1992).
16. Vilcek J, Lee TH: Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313-7316 (1991).
17. Vlassara H: Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41 (Suppl 2): 52-56 (1992).
18. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science. 240: 1546-1548 (1988).
19. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, McDevitt HO: Effect of tumor necrosis factor a on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180: 995-1004 (1994).